Seeing hope: FDA panel considers gene therapy for blindness

In this Monday, Oct. 2, 2017, photo, Beth Guardino, left, hugs her son, Christian, as they talk about the 17-year-old’s life before and after gene therapy for his hereditary blindness during an interview at their home in Patchogue, N.Y. Christian was diagnosed with hereditary blindness and received gene therapy as part of a study. On Thursday, Oct. 12, U.S. Food and Drug Administration advisers will consider whether to recommend approval of the gene therapy. (AP Photo/Julie Jacobson)

0 Comments

Your email address will not be published. Required fields are marked *

*

By participating in online discussions you acknowledge that you have agreed to the TERMS OF SERVICE. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. To report comments that you believe do not follow our guidelines, send us an email.